share_log

Sharps Technology And Roncadelle Operations Sign Worldwide Sales And Distribution Agreement For Their Innovative Portfolio Of Safe Technology Drug Delivery Systems

Benzinga ·  Mar 7 08:03

Sharps Technology, Inc., (NASDAQ: "STSS" and "STSSW"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, and Roncadelle Operations, a driving force in the development of novel medical drug delivery devices, have signed a sales and distribution agreement to cooperatively sell and distribute each other's products to their respective areas of influence. The agreement expands Sharps' American-based product market into Europe, the Middle East, Africa, and the Asia-Pacific region, and opens Roncadelle's reach into the dynamic North American and Latin American markets. The agreement, signed on March 4, 2024, lays the groundwork...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment